AndrewGregorySikoraMD
Otolaryngology (ENT) • Houston, TXAssistant Professor, Otolaryngology, Icahn School of Medicine
Are you Dr. Sikora?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Andrew Sikora, MD is an otolaryngologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Arizona. He is an Assistant Professor at Icahn School of Medicine.
Education & Training
Albert Einstein College of MedicineClass of 2000
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
OK State Medical License 2023 - 2025
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology- Join now to see all
Publications & Presentations
PubMed
- 1 citationsLocalized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders.Nourhan I Hussein, Andrea H Molina, Gemalene M Sunga, Moran Amit, Yu Leo Lei
Oral Oncology. 2024-11-01 - 2 citationsOral Pre-malignancy: An Update on Novel Therapeutic Approaches.Shorook Naara, Clara Andrews, Andrew Sikora, Michelle Williams, Mark Chambers
Current Oncology Reports. 2024-09-01 - Genetic variations associated with telomere length predict the risk of recurrence of non-oropharyngeal head and neck squamous cell carcinoma.Peng Sun, Kyle J Gu, Guibin Zheng, Andrew G Sikora, Chao Li
Molecular Carcinogenesis. 2024-09-01
Press Mentions
UTHealth Oral Surgeon Is the Second in US with Active R01 Grant FundingAugust 20th, 2021- PPIs Sensitize Cancer Cells to Radiation Therapy to Improve Tumor ControlJuly 8th, 2021
Checkpoint Inhibitors with Surgery and Radiotherapy Offer Promise in Head and Neck CancersJune 6th, 2016- Join now to see all
